CLDI logo

Calidi Biotherapeutics (CLDI) EBITDA

Annual EBITDA

-$26.88 M
-$1.87 M-7.48%

December 31, 2023


Summary


Performance

CLDI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIprofitabilitymetrics:

Quarterly EBITDA

-$4.45 M
+$660.00 K+12.92%

September 30, 2024


Summary


Performance

CLDI Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIprofitabilitymetrics:

TTM EBITDA

-$23.80 M
-$3.10 M-15.00%

September 30, 2024


Summary


Performance

CLDI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CLDI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.5%-230.9%+11.2%
3 y3 years-251.2%-230.9%+11.2%
5 y5 years-251.2%-230.9%+11.2%

CLDI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-164.7%at low-230.9%+62.4%-604.2%+22.7%
5 y5-year-251.2%at low-230.9%+62.4%-604.2%+22.7%
alltimeall time-251.2%at low-230.9%+62.4%-604.2%+22.7%

Calidi Biotherapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.45 M(-12.9%)
-$23.80 M(+15.0%)
Jun 2024
-
-$5.11 M(-22.5%)
-$20.69 M(-24.5%)
Mar 2024
-
-$6.59 M(-13.8%)
-$27.41 M(+2.0%)
Dec 2023
-$26.88 M
-$7.65 M(+468.9%)
-$26.88 M(+0.2%)
Sep 2023
-
-$1.34 M(-88.6%)
-$26.81 M(-12.9%)
Jun 2023
-
-$11.83 M(+95.2%)
-$30.79 M(+62.4%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$6.06 M(-20.1%)
-$18.96 M(+46.9%)
Dec 2022
-$25.00 M(+146.2%)
-
-
Dec 2022
-
-$7.58 M(+42.3%)
-$12.90 M(+48.3%)
Sep 2022
-
-$5.33 M(+57.6%)
-$8.70 M(+157.6%)
Dec 2021
-$10.15 M(+32.7%)
-$3.38 M
-$3.38 M
Dec 2020
-$7.65 M
-
-

FAQ

  • What is Calidi Biotherapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics annual EBITDA year-on-year change?
  • What is Calidi Biotherapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics quarterly EBITDA year-on-year change?
  • What is Calidi Biotherapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics TTM EBITDA year-on-year change?

What is Calidi Biotherapeutics annual EBITDA?

The current annual EBITDA of CLDI is -$26.88 M

What is the all time high annual EBITDA for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high annual EBITDA is -$7.65 M

What is Calidi Biotherapeutics annual EBITDA year-on-year change?

Over the past year, CLDI annual EBITDA has changed by -$1.87 M (-7.48%)

What is Calidi Biotherapeutics quarterly EBITDA?

The current quarterly EBITDA of CLDI is -$4.45 M

What is the all time high quarterly EBITDA for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high quarterly EBITDA is -$1.34 M

What is Calidi Biotherapeutics quarterly EBITDA year-on-year change?

Over the past year, CLDI quarterly EBITDA has changed by -$3.10 M (-230.95%)

What is Calidi Biotherapeutics TTM EBITDA?

The current TTM EBITDA of CLDI is -$23.80 M

What is the all time high TTM EBITDA for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high TTM EBITDA is -$3.38 M

What is Calidi Biotherapeutics TTM EBITDA year-on-year change?

Over the past year, CLDI TTM EBITDA has changed by +$3.01 M (+11.24%)